Takeda Pharmaceutical Li... (TAK)
14.78
-0.27 (-1.79%)
At close: Mar 31, 2025, 10:12 AM
13F Institute Ownership
Total Institutes of 294 in Takeda Pharmaceutical reduced their positions with a decrease of 10 investors compared to the previous quarter. A reduction of 4.17M shares, as total invested capital declined by $61.95M with ownership percentage dropping from 4.81% to 4.55%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.020
0.02
Call Flow 1,721,000
98%
Put Flow 35,100
2%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Capital Research Global Invest... | 0.83% | 13.16M | +0.19% | 174.27M | 0.04% |
| Morgan Stanley | 0.35% | 5.6M | +4.59% | 74.15M | < 0.01% |
| Goldman Sachs Group Inc | 0.29% | 4.63M | +1.48% | 61.28M | < 0.01% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.